# Alamar Biosciences Inc. (ALMR) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $30.80, market value $2.1 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Alamar Biosciences Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 25.2×**. Each dollar of revenue is priced at 25.2×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 6.8×**. The shares trade at 6.8× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -2.9%**. Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 55.7%**. Alamar Biosciences Inc. keeps 55.7% of revenue after the direct cost of what it sells.
- **Operating margin: -50.0%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -40.2%**. The company reported a net loss over the last twelve months.
- **Return on equity: 18.8%**. 18.8% on shareholders' equity is solid.
- **Return on invested capital: 22.7%**. Return on all capital, debt included, is 22.7%: comfortably above what that capital costs.
- **Return on assets: -35.1%**. Each dollar of assets produces -35.1% of profit.

## Growth
- **Revenue growth (1 yr): 195.2%**. Revenue grew 195.2% over the last year.
- **EPS growth (1 yr): 36.7%**. Earnings per share rose 36.7%, slower than revenue, so margins compressed.

## Financial health
- **Net debt / EBITDA: net cash**. Alamar Biosciences Inc. holds more cash than debt.
- **Current ratio: 3.99** (quick 2.37). Current assets cover the next year's liabilities 3.99 times.
- **Altman Z-score: 3.10**. A Z-score of 3.10 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 4/9**. 4 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Alamar Biosciences Inc. does not currently pay a dividend.

## Price and momentum
- **From 52-week high: -20.1%** (63.4% above the low). Trading 20% below its 52-week high.
- **RSI (14-day): 51**. An RSI of 51 is neutral.
- **Beta (1 yr): 0.66** (volatility 82%). Beta of 0.66 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ALMR · Page: https://foliofundamentals.com/stocks/almr

Not investment advice.